A comparison of pregnancies that occur before and after the onset of chronic fatigue syndrome.
Schacterle, Richard S, Komaroff, Anthony L · Archives of internal medicine · 2004 · DOI
Quick Summary
This study surveyed 86 women with ME/CFS about their pregnancies before and after developing the illness. During pregnancy, about 4 in 10 women had no change in symptoms, 3 in 10 improved, and 3 in 10 worsened. The study found that pregnancy itself did not consistently make ME/CFS worse, and most pregnancy outcomes were similar whether the illness was present or not, though miscarriage rates were higher in pregnancies after ME/CFS onset.
Why It Matters
Many women with ME/CFS delay or avoid pregnancy due to concerns about disease progression and fetal harm. This study provides direct patient-reported data suggesting pregnancy outcomes are generally reassuring, though specific risks (miscarriage, childhood developmental delays) warrant further investigation. Understanding these risks helps women with ME/CFS make informed reproductive decisions.
Observed Findings
During pregnancy: 41% of women had no symptom change, 30% improved, and 29% worsened
Post-pregnancy: 30% had no symptom change, 20% improved, and 50% worsened
Spontaneous abortion rate was 30% (22/73) in pregnancies after CFS onset vs 8% (13/171) before onset (P<.001)
Developmental delays or learning disabilities were reported in 21% (9/43) of children born after maternal CFS onset vs 8% (11/139) born before onset (P=.01)
Most other maternal and infant complications showed no significant differences between the two groups
Inferred Conclusions
Pregnancy does not consistently worsen ME/CFS symptoms and should not be categorically discouraged on grounds of symptom exacerbation
Most maternal and neonatal outcomes are similar regardless of CFS onset timing, suggesting pregnancy is generally feasible for women with ME/CFS
Higher rates of miscarriage and childhood developmental delays after CFS onset warrant investigation but may reflect confounding factors rather than direct disease causation
Larger prospective studies with control populations are needed to clarify whether ME/CFS itself increases these specific risks
Remaining Questions
What role do maternal age, disease severity, and disease duration play in the observed higher miscarriage and developmental delay rates?
What This Study Does Not Prove
This study does not prove that ME/CFS causes miscarriage or developmental delays—only that they occurred more frequently in the post-CFS pregnancy group, which could reflect unmeasured confounders like maternal age or disease severity rather than causation. The cross-sectional, retrospective design relies on recall and lacks a matched control population. Findings do not establish safe or unsafe thresholds for pregnancy in ME/CFS.
Tags
Symptom:Fatigue
Method Flag:Weak Case DefinitionNo ControlsSmall SampleExploratory Only
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Do pregnancy outcomes differ based on ME/CFS symptom severity or specific symptom profiles at conception?
Are developmental delays in children attributable to prenatal factors, postnatal maternal illness effects on parenting, or shared genetic/environmental factors?
What is the natural history of CFS symptom changes in the postpartum period—do the 50% experiencing worsening recover over time?